Go-CHOP as the Frontline Therapy for PTCL

NCT05963347 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER_GOV

Sponsor class

Conditions

Peripheral T Cell Lymphoma

Interventions

DRUG: Golidocitinib
DRUG: CHOP Regimen

Sponsor

Henan Cancer Hospital